Cargando…

Resolution of a chronic viral infection after interleukin-10 receptor blockade

A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this pape...

Descripción completa

Detalles Bibliográficos
Autores principales: Ejrnaes, Mette, Filippi, Christophe M., Martinic, Marianne M., Ling, Eleanor M., Togher, Lisa M., Crotty, Shane, von Herrath, Matthias G.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118120/
https://www.ncbi.nlm.nih.gov/pubmed/17030951
http://dx.doi.org/10.1084/jem.20061462
_version_ 1782140952954011648
author Ejrnaes, Mette
Filippi, Christophe M.
Martinic, Marianne M.
Ling, Eleanor M.
Togher, Lisa M.
Crotty, Shane
von Herrath, Matthias G.
author_facet Ejrnaes, Mette
Filippi, Christophe M.
Martinic, Marianne M.
Ling, Eleanor M.
Togher, Lisa M.
Crotty, Shane
von Herrath, Matthias G.
author_sort Ejrnaes, Mette
collection PubMed
description A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this paper, we report that IL-10 production is drastically increased in mice persistently infected with lymphocytic choriomeningitis virus. In vivo blockade of the IL-10 receptor (IL-10R) with a neutralizing antibody resulted in rapid resolution of the persistent infection. IL-10 secretion was diminished and interferon γ production by antiviral CD8(+) T cells was enhanced. In persistently infected mice, CD8α(+) dendritic cell (DC) numbers declined early after infection, whereas CD8α(−) DC numbers were not affected. CD8α(−) DCs supported IL-10 production and subsequent dampening of antiviral T cell responses. Therapeutic IL-10R blockade broke the cycle of IL-10–mediated immune suppression, preventing IL-10 priming by CD8α(−) DCs and enhancing antiviral responses and thereby resolving infection without causing immunopathology.
format Text
id pubmed-2118120
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21181202007-12-13 Resolution of a chronic viral infection after interleukin-10 receptor blockade Ejrnaes, Mette Filippi, Christophe M. Martinic, Marianne M. Ling, Eleanor M. Togher, Lisa M. Crotty, Shane von Herrath, Matthias G. J Exp Med Articles A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this paper, we report that IL-10 production is drastically increased in mice persistently infected with lymphocytic choriomeningitis virus. In vivo blockade of the IL-10 receptor (IL-10R) with a neutralizing antibody resulted in rapid resolution of the persistent infection. IL-10 secretion was diminished and interferon γ production by antiviral CD8(+) T cells was enhanced. In persistently infected mice, CD8α(+) dendritic cell (DC) numbers declined early after infection, whereas CD8α(−) DC numbers were not affected. CD8α(−) DCs supported IL-10 production and subsequent dampening of antiviral T cell responses. Therapeutic IL-10R blockade broke the cycle of IL-10–mediated immune suppression, preventing IL-10 priming by CD8α(−) DCs and enhancing antiviral responses and thereby resolving infection without causing immunopathology. The Rockefeller University Press 2006-10-30 /pmc/articles/PMC2118120/ /pubmed/17030951 http://dx.doi.org/10.1084/jem.20061462 Text en Copyright © 2006, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Ejrnaes, Mette
Filippi, Christophe M.
Martinic, Marianne M.
Ling, Eleanor M.
Togher, Lisa M.
Crotty, Shane
von Herrath, Matthias G.
Resolution of a chronic viral infection after interleukin-10 receptor blockade
title Resolution of a chronic viral infection after interleukin-10 receptor blockade
title_full Resolution of a chronic viral infection after interleukin-10 receptor blockade
title_fullStr Resolution of a chronic viral infection after interleukin-10 receptor blockade
title_full_unstemmed Resolution of a chronic viral infection after interleukin-10 receptor blockade
title_short Resolution of a chronic viral infection after interleukin-10 receptor blockade
title_sort resolution of a chronic viral infection after interleukin-10 receptor blockade
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118120/
https://www.ncbi.nlm.nih.gov/pubmed/17030951
http://dx.doi.org/10.1084/jem.20061462
work_keys_str_mv AT ejrnaesmette resolutionofachronicviralinfectionafterinterleukin10receptorblockade
AT filippichristophem resolutionofachronicviralinfectionafterinterleukin10receptorblockade
AT martinicmariannem resolutionofachronicviralinfectionafterinterleukin10receptorblockade
AT lingeleanorm resolutionofachronicviralinfectionafterinterleukin10receptorblockade
AT togherlisam resolutionofachronicviralinfectionafterinterleukin10receptorblockade
AT crottyshane resolutionofachronicviralinfectionafterinterleukin10receptorblockade
AT vonherrathmatthiasg resolutionofachronicviralinfectionafterinterleukin10receptorblockade